五月激情综合美女久久,安徽妇搡BBBB搡BBBB袄爱直播,国产做爰XXXⅩ高潮视频12p,女人野外做爰A片妓女潘金莲,蜜桃又粗又爽成人www网站

Alzheimer’s disease early diagnostic and staging biomarkers revealed by large-scale cerebrospinal fluid and serum proteomic profiling

Release time: Publisher:MKT Dept Reading times:


【PUBLIC SUMMARY】:

- In-depth proteomics workflow for profiling paired cerebrospinal fluid (CSF) and serum proteomes.
- Independent multicenter set combined with multiple methods for validation.
- Development of 19 CSF- and 8 serum-protein panels for early of Alzheimer disease (AD) diagnosis.
- Twenty-one CSF and 18 serum proteins dysregulated in different AD stages.
- Groundwork laid for AD blood tests in clinical screening and staging.


Amyloid-β, tau pathology, and biomarkers of neurodegeneration make up the core diagnostic biomarkers of Alzheimer disease (AD). However, these proteins represent only a fraction of the complex biological processes underlying AD, and individuals with other brain diseases in which AD pathology is a comorbidity also test positive for these diagnostic biomarkers. More AD-specific early diagnostic and disease staging biomarkers are needed. In this study, we performed tandem mass tag proteomic analysis of paired cerebrospinal fluid (CSF) and serum samples in a discovery cohort comprising 98 participants. Candidate biomarkers were validated by parallel reaction monitoring–based targeted proteomic assays in an independent multicenter cohort comprising 288 participants. We quantified 3,238 CSF and 1,702 serum proteins in the discovery cohort, identifying 171 and 860 CSF proteins and 37 and 323 serum proteins as potential early diagnostic and staging biomarkers, respectively. In the validation cohort, 58 and 21 CSF proteins, as well as 12 and 18 serum proteins, were verified as early diagnostic and staging biomarkers, respectively. Separate 19-protein CSF and an 8-protein serum biomarker panels were built by machine learning to accurately classify mild cognitive impairment (MCI) due to AD from normal cognition with areas under the curve of 0.984 and 0.881, respectively. The 19-protein CSF biomarker panel also effectively discriminated patients with MCI due to AD from patients with other neurodegenerative diseases. Moreover, we identified 21 CSF and 18 serum stage-associated proteins reflecting AD stages. Our findings provide a foundation for developing blood-based tests for AD screening and staging in clinical practice.



【Blood biomarker assessment】: Serum GFAP and NEFL were quantified by commercially available Single Molecular Immunity Detection kits (Astrabio, R14060 and R14040). All of the measurements were conducted on an AST-Sc-Lite analyzer (Astrabio) and were performed according to the manufacturer’s instructions.



DOI https://doi.org/10.1016/j.xinn.2023.100544

无码粉嫩极品尤物在线综合 | 性感丰满爆乳少妇无码中出福利视频 | 少妇白浆一区二区按摩 | 五十路熟妇亚洲AV无码 | 国产做a爱一级毛片久久 | 欧美成人午夜无码A片秀色直播 | 青青草国产精品一区二区小说 | 奴役变态调教一区二区三区 | 精品国婬伦v无码久久久黑人 | 国产Av亚洲AⅤ高潮无 | 91无码精品秘 入口国产 | 熟女 人妻蜜臀av一区二区三区 | 少妇婬荡视频在线播放 | 成人做爰高潮免费视频 | 国产婬乱片A片AAA毛片下载 | 亚洲铁杆无码在线观看视频 | 亚洲AV无码乱码在线观看性色 | 国产精品 在线播放 | 十分钟做a小视频免费观看 91极品人妻国产综合韩国 | 国产精品a久久久久久 | 欧美日韩中文字幕久久 | 精品无码一区二区人妻久久蜜桃 | 亚洲日韩精品无码一区 | 精品无码一区二区人妻久久蜜桃 | 欧一美一色一伦一区二区三区 | 高潮到失禁变态另类视频 | 少妇毛片一区二区三区粉嫩aV | 国产级AA大片免费久久久久久 | 国产91探花精品一区二区 | 近親相姦中文字幕A片 | 人妻体体内射精一区二区 | 国产 高潮 喷水 白浆 黑人 | 日本无码白浆一区二区 | 少妇做爰特黄A片免费看女澡堂 | 久久久久久久久久久av | 日本人妻系列中文字幕 | 日韩国产精品一级毛片在线 | 亚洲AV成人一区二区三区观看 | 午夜精品A片一二三区蜜臀 欧美一区二区三欧A片直播 | 国产真实乱婬A片三区高 | 日本A一片中国A一片 |